Role of bone-forming agents in the management of osteoporosis

被引：27
|
作者：
McClung, Michael R. [1 ,2 ]
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR 97225 USA
[2] Australian Catholic Univ, Mary MacKillop Ctr Hlth Res, Melbourne, Vic, Australia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2021年 / 33卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Osteoporosis; Osteoanabolic; Abaloparatide; Romosozumab; Teriparatide; Sequence;
D O I：
10.1007/s40520-020-01708-8
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Recent evidence confirms the superiority of osteoanabolic therapy compared to anti-remodeling drugs for rapid improvement in bone density and fracture risk reduction, providing strong justification for the use of these anabolic agents as the initial therapy in high-risk patients, to be followed by anti-remodeling therapy. This review will highlight the results of recent studies and define the current status of osteoanabolic therapy for osteoporosis.
引用
收藏
页码：775 / 791
页数：17
相关论文
共 50 条
  • [1] Role of bone-forming agents in the management of osteoporosis
    Michael R. McClung
    Aging Clinical and Experimental Research, 2021, 33 : 775 - 791
  • [2] Bone-forming agents in the management of osteoporosis
    Neuprez, Audrey
    Reginster, Jean-Yves
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (05) : 869 - 883
  • [3] Treatment of Osteoporosis: Role of Bone-Forming Agents
    J.-Y. Reginster
    V. Halkin
    Y. Henrotin
    C. Gosset
    Osteoporosis International, 1999, 9 (Suppl 2) : S91 - S96
  • [4] Treatment of osteoporosis: Role of bone-forming agents
    Reginster, JY
    Halkin, V
    Henrotin, Y
    Gosset, C
    OSTEOPOROSIS INTERNATIONAL, 1999, 9 : 91 - 96
  • [5] Use of antiresorptives and bone-forming agents in the management of osteoporosis
    Finkelstein, JS
    BONE, 2005, 36 : S475 - S475
  • [6] The parathyroid hormones: Bone-forming agents for treatment of osteoporosis
    Whitfield, JF
    Morley, P
    Willick, GE
    MEDSCAPE WOMENS HEALTH, 2000, 5 (05):
  • [7] Bone-forming agents
    Meunier, PJ
    OSTEOPOROSIS 1996, 1996, 1118 : 305 - 313
  • [8] Current Status of Bone-Forming Therapies for the Management of Osteoporosis
    Solling, Anne Sophie Koldkjaer
    Harslof, Torben
    Langdahl, Bente
    DRUGS & AGING, 2019, 36 (07) : 625 - 638
  • [9] Current Status of Bone-Forming Therapies for the Management of Osteoporosis
    Anne Sophie Koldkjær Sølling
    Torben Harsløf
    Bente Langdahl
    Drugs & Aging, 2019, 36 : 625 - 638
  • [10] New bone-forming treatments for osteoporosis
    Socrates E. Papapoulos
    Nature Reviews Endocrinology, 2015, 11 (2) : 69 - 70
12345